CSX
57
13
IP
68
-2
PRU
62
-3
GILD
50
-6
CCI
41
-3
FIS
50
-5
MSFT
62
9
ICE
50
-5
YUM
62
-4
NSC
65
12
MA
41
-5
ISRG
50
-4
PFE
33
-3
MMM
52
-4
NWS
78
-2
A
62
-2
PGR
33
-4
VTR
44
6
ORLY
64
10
HBI
62
-5
CSX
57
13
IP
68
-2
PRU
62
-3
GILD
50
-6
CCI
41
-3
FIS
50
-5
MSFT
62
9
ICE
50
-5
YUM
62
-4
NSC
65
12
MA
41
-5
ISRG
50
-4
PFE
33
-3
MMM
52
-4
NWS
78
-2
A
62
-2
PGR
33
-4
VTR
44
6
ORLY
64
10
HBI
62
-5
Financhill
Back

Hoth Therapeutics 10K Form

Sell
49

HOTH
Hoth Therapeutics

Last Price:
$1.43
Seasonality Move:
-23.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HOTH News And Ratings

See the #1 stock for the next 7 days that we like better than HOTH

HOTH Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-2.8M
Price / Cash Flow: 0
Annual Sales: $0.88
Price / Book: 1.65

Profitability

EPS (TTM): -1.14000
Net Income (TTM): $-9.6M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Hoth Therapeutics Earnings Forecast

Key Hoth Therapeutics Financial Ratios

  • Per Share Earnings over the last 7 years have been positive in 4 years.

Hoth Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: HOTH
CUSIP: 44148G
Website: hoththerapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

HOTH Technical Analysis vs Fundamental Analysis

Sell
49
Hoth Therapeutics (HOTH) is a Sell

Is Hoth Therapeutics a Buy or a Sell?

  • Hoth Therapeutics stock is rated a Sell
    The current Hoth Therapeutics [HOTH] share price is $1.44. The Score for HOTH is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.